These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 16253311)

  • 1. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
    Woo JJ
    Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA perspectives on supplement use by patients on antithrombotic therapy.
    Kim MJ
    Thromb Res; 2005; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297
    [No Abstract]   [Full Text] [Related]  

  • 3. Inappropriate advertising of dietary supplements.
    de Lemos ML
    N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12774807
    [No Abstract]   [Full Text] [Related]  

  • 4. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ; Clauson KA
    J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
    Dodge T; Kaufman A
    Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate advertising of dietary supplements.
    Taylor H
    N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12773657
    [No Abstract]   [Full Text] [Related]  

  • 7. Injecting Safety into Supplements - Modernizing the Dietary Supplement Law.
    Cohen PA; Bass S
    N Engl J Med; 2019 Dec; 381(25):2387-2389. PubMed ID: 31851798
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternative medicine--the case of herbal remedies.
    Dickinson A
    N Engl J Med; 1999 Feb; 340(7):564; author reply 566. PubMed ID: 10026039
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-39. PubMed ID: 21374841
    [No Abstract]   [Full Text] [Related]  

  • 10. Premarket notifications of new dietary ingredients--a ten-year review.
    McGuffin M; Young AL
    Food Drug Law J; 2004; 59(2):229-44. PubMed ID: 15318394
    [No Abstract]   [Full Text] [Related]  

  • 11. Labeling and manufacturing standards proposed for all dietary supplements.
    Horrigan B; Block B
    Altern Ther Health Med; 2003; 9(3):22. PubMed ID: 12776471
    [No Abstract]   [Full Text] [Related]  

  • 12. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 13. The Dietary Supplement and Health Education Act and supplements: dietary and nutritional supplements need no more regulations.
    Wollschlaeger B
    Int J Toxicol; 2003; 22(5):387-90. PubMed ID: 14555412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate advertising of dietary supplements.
    Applequist WL
    N Engl J Med; 2003 May; 348(22):2255-6; author reply 2255-6. PubMed ID: 12774809
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA, off-label use, and informed consent: debunking myths and misconceptions.
    Beck JM; Azari ED
    Food Drug Law J; 1998; 53(1):71-104. PubMed ID: 11795338
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(201):59714-5. PubMed ID: 14567392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the dietary supplement health and education act on consumer beliefs about the safety and effectiveness of dietary supplements.
    Dodge T; Litt D; Kaufman A
    J Health Commun; 2011 Mar; 16(3):230-44. PubMed ID: 21120738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deterring inefficient pharmaceutical litigation: an economic rationale for the FDA regulatory compliance defense.
    Viscusi WK; Rowland SR; Dorfman HL; Walsh CJ
    Spec Law Dig Health Care Law; 1996 Mar; (205):9-52. PubMed ID: 10156421
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(4):1000-50. PubMed ID: 11010621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good law from tragic facts--Congress, the FDA, and preemption.
    Annas GJ
    N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.